Fundraising Fox

Susa Ventures β€” 2024 Investments

4 investments dated 2024 Β· listed companies and verified rows first Β· show all

Centaurcentaur.aiin𝕏Oct 2024 Β· $16M

Centaur.ai uses performance-based AI and collective intelligence methods to improve medical decision-making in skin lesion assessment for cancer detection.

AI & Machine LearningData & InfrastructureHealthtechMedical DevicesBoston, US

Erik Duhaime(Founder)inTom Gellatly(Founder)inZach Rausnitz(Founder)in

Co-investorsSBXiY CombinatorAccelAlumni VenturesMatrixSamsung Next+1 more

Centaur Labscentaurlabs.comin𝕏Oct 2024 Β· $16M

Centaur.ai combines human medical professionals' assessments with AI algorithms to improve diagnostic accuracy for skin lesion evaluation and cancer detection.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechMedical Devices

Erik Duhaime

Co-investors186 VenturesAccelAlumni VenturesBasecamp FundMatrixOmega Venture Partners+3 more

Qodoqodo.aiin𝕏Sep 2024 Β· $40M

Qodo provides AI-powered code review and code quality governance for enterprise engineering teams, using specialized review agents and a context engine that reason over a full codebase to flag bugs, rule violations, and requirement gaps.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareNew York City, US

Itamar Friedman(Founder)in

Co-investorsMaor InvestmentsSquare Peg CapitalTLV PartnersFirestreak VenturesQumra Capital

Runhappy INCUBATED Marketing New Yorktildei.comin𝕏Oct 2024

Runhappy (Tildei) automates event and booking inquiry management for experience venues and entertainment operators, capturing inquiries across web, SMS, email, and voice 24/7 and working them through to confirmed bookings.

AI & Machine LearningSaaSSales TechNew York City, US

Kevin Dutra(Founder)inManisha Shah(Founder)Mark Ghermezian(Executive Officer, Director, Promoter)

Co-investorsGradient Venturesm]x[v CapitalMaccabee VenturesVine VenturesLerer HippeauLudlow Ventures+1 more

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.